• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类T细胞受体结合亲和力受主要组织相容性复合体(MHC)类限制的支配。

Human TCR-binding affinity is governed by MHC class restriction.

作者信息

Cole David K, Pumphrey Nicholas J, Boulter Jonathan M, Sami Malkit, Bell John I, Gostick Emma, Price David A, Gao George F, Sewell Andrew K, Jakobsen Bent K

机构信息

Nuffield Department of Clinical Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.

出版信息

J Immunol. 2007 May 1;178(9):5727-34. doi: 10.4049/jimmunol.178.9.5727.

DOI:10.4049/jimmunol.178.9.5727
PMID:17442956
Abstract

T cell recognition is initiated by the binding of TCRs to peptide-MHCs (pMHCs), the interaction being characterized by weak affinity and fast kinetics. Previously, only 16 natural TCR/pMHC interactions have been measured by surface plasmon resonance (SPR). Of these, 5 are murine class I, 5 are murine class II, and 6 are human class I-restricted responses. Therefore, a significant gap exists in our understanding of human TCR/pMHC binding due to the limited SPR data currently available for human class I responses and the absence of SPR data for human class II-restricted responses. We have produced a panel of soluble TCR molecules originating from human T cells that respond to naturally occurring disease epitopes and their cognate pMHCs. In this study, we compare the binding affinity and kinetics of eight class-I-specific TCRs (TCR-Is) to pMHC-I with six class-II-specific TCRs (TCR-IIs) to pMHC-II using SPR. Overall, there is a substantial difference in the TCR-binding equilibrium constants for pMHC-I and pMHC-II, which arises from significantly faster on-rates for TCRs binding to pMHC-I. In contrast, the off-rates for all human TCR/pMHC interactions fall within a narrow window regardless of class restriction, thereby providing experimental support for the notion that binding half-life is the principal kinetic feature controlling T cell activation.

摘要

T细胞识别是由TCR与肽-主要组织相容性复合体(pMHC)结合启动的,这种相互作用的特点是亲和力弱且动力学速度快。此前,通过表面等离子体共振(SPR)仅测量了16种天然TCR/pMHC相互作用。其中,5种是小鼠I类,5种是小鼠II类,6种是人类I类限制反应。因此,由于目前可用于人类I类反应的SPR数据有限,且缺乏人类II类限制反应的SPR数据,我们对人类TCR/pMHC结合的理解存在显著差距。我们制备了一组源自人类T细胞的可溶性TCR分子,它们对天然存在的疾病表位及其同源pMHC有反应。在本研究中,我们使用SPR比较了8种I类特异性TCR(TCR-I)与pMHC-I的结合亲和力和动力学,以及6种II类特异性TCR(TCR-II)与pMHC-II的结合亲和力和动力学。总体而言,pMHC-I和pMHC-II的TCR结合平衡常数存在显著差异,这是由于TCR与pMHC-I结合的结合速率明显更快。相比之下,所有人类TCR/pMHC相互作用的解离速率都在一个狭窄的范围内,而与类别限制无关,从而为结合半衰期是控制T细胞激活的主要动力学特征这一观点提供了实验支持。

相似文献

1
Human TCR-binding affinity is governed by MHC class restriction.人类T细胞受体结合亲和力受主要组织相容性复合体(MHC)类限制的支配。
J Immunol. 2007 May 1;178(9):5727-34. doi: 10.4049/jimmunol.178.9.5727.
2
Genome-wide structural modelling of TCR-pMHC interactions.TCR-pMHC相互作用的全基因组结构建模
BMC Genomics. 2013;14 Suppl 5(Suppl 5):S5. doi: 10.1186/1471-2164-14-S5-S5. Epub 2013 Oct 16.
3
TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity.TCR-肽-MHC 相互作用的原位显示出加速的动力学和增加的亲和力。
Nature. 2010 Feb 18;463(7283):963-7. doi: 10.1038/nature08746.
4
Force-Regulated In Situ TCR-Peptide-Bound MHC Class II Kinetics Determine Functions of CD4+ T Cells.力调节原位TCR-肽结合的II类主要组织相容性复合体动力学决定CD4+T细胞的功能。
J Immunol. 2015 Oct 15;195(8):3557-64. doi: 10.4049/jimmunol.1501407. Epub 2015 Sep 2.
5
Peptide-MHC Binding Reveals Conserved Allosteric Sites in MHC Class I- and Class II-Restricted T Cell Receptors (TCRs).肽-MHC 结合揭示了 MHC I 类和 II 类限制性 T 细胞受体 (TCR) 中的保守变构位点。
J Mol Biol. 2020 Dec 4;432(24):166697. doi: 10.1016/j.jmb.2020.10.031. Epub 2020 Nov 4.
6
Quantifying conformational changes in the TCR:pMHC-I binding interface.量化TCR:pMHC-I结合界面中的构象变化。
Front Immunol. 2024 Dec 2;15:1491656. doi: 10.3389/fimmu.2024.1491656. eCollection 2024.
7
How TCRs bind MHCs, peptides, and coreceptors.T细胞受体如何结合主要组织相容性复合体、肽和共受体。
Annu Rev Immunol. 2006;24:419-66. doi: 10.1146/annurev.immunol.23.021704.115658.
8
Geometrical characterization of T cell receptor binding modes reveals class-specific binding to maximize access to antigen.T 细胞受体结合模式的几何特征揭示了类特异性结合以最大限度地获得抗原。
Proteins. 2020 Mar;88(3):503-513. doi: 10.1002/prot.25829. Epub 2019 Oct 21.
9
Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC.共受体对 MHC 的亲和力决定了 TCR 与共刺激肽-MHC 相互作用的肽特异性要求。
J Exp Med. 2013 Aug 26;210(9):1807-21. doi: 10.1084/jem.20122528. Epub 2013 Aug 12.
10
Structure-Directed Pan-Specific T-Cell Receptor-Peptide-Major Histocompatibility Complex Interaction Prediction.基于结构的泛特异性T细胞受体-肽-主要组织相容性复合体相互作用预测
J Chem Inf Model. 2025 May 12;65(9):4674-4686. doi: 10.1021/acs.jcim.5c00055. Epub 2025 Apr 29.

引用本文的文献

1
A novel decoding strategy for ProteinMPNN to design with less visibility to cytotoxic T-lymphocytes.一种用于ProteinMPNN的新型解码策略,旨在设计出对细胞毒性T淋巴细胞可见性较低的蛋白质。
Comput Struct Biotechnol J. 2025 Aug 13;27:3693-3703. doi: 10.1016/j.csbj.2025.07.055. eCollection 2025.
2
A CD1c lipid agnostic T cell receptor bispecific engager redirects T cells against CD1c cells.一种CD1c脂质无特异性T细胞受体双特异性衔接器可使T细胞重新定向攻击CD1c细胞。
Front Immunol. 2025 Jul 24;16:1614610. doi: 10.3389/fimmu.2025.1614610. eCollection 2025.
3
T cell receptor mimic CAR T cells targeting cathepsin G signal peptide.
靶向组织蛋白酶G信号肽的T细胞受体模拟嵌合抗原受体T细胞
Leukemia. 2025 May 28. doi: 10.1038/s41375-025-02652-0.
4
A general system for targeting MHC class II-antigen complex via a single adaptable loop.一种通过单个可适配环靶向MHC II类抗原复合物的通用系统。
Nat Biotechnol. 2024 Dec 13. doi: 10.1038/s41587-024-02466-y.
5
Mechanisms governing bystander activation of T cells.T细胞旁观者激活的调控机制。
Front Immunol. 2024 Nov 27;15:1465889. doi: 10.3389/fimmu.2024.1465889. eCollection 2024.
6
CRISPR-Cas9 screening reveals a distinct class of MHC-I binders with precise HLA-peptide recognition.CRISPR-Cas9筛选揭示了一类具有精确HLA-肽识别能力的独特MHC-I结合物。
iScience. 2024 May 27;27(6):110120. doi: 10.1016/j.isci.2024.110120. eCollection 2024 Jun 21.
7
-Interacting Plasma Membrane Proteins and Binding Partner Identification.相互作用的质膜蛋白和结合伴侣鉴定。
J Proteome Res. 2024 Aug 2;23(8):3322-3331. doi: 10.1021/acs.jproteome.4c00289. Epub 2024 Jun 27.
8
Can AlphaFold's breakthrough in protein structure help decode the fundamental principles of adaptive cellular immunity?阿尔法折叠在蛋白质结构方面的突破能否有助于破译适应性细胞免疫的基本原理?
Nat Methods. 2024 May;21(5):766-776. doi: 10.1038/s41592-024-02240-7. Epub 2024 Apr 23.
9
Selection, engineering, and in vivo testing of a human leukocyte antigen-independent T-cell receptor recognizing human mesothelin.人白细胞抗原非依赖的识别人间皮素的 T 细胞受体的选择、工程改造和体内测试。
PLoS One. 2024 Apr 4;19(4):e0301175. doi: 10.1371/journal.pone.0301175. eCollection 2024.
10
Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy.利用免疫基因组学方法对可靶向的新抗原进行优先级排序,以实现个性化癌症免疫治疗。
Front Immunol. 2023 Dec 12;14:1301100. doi: 10.3389/fimmu.2023.1301100. eCollection 2023.